AHP Partner and Consulting Actuary, Greg Warren, FSA, FCA, MAAA was quoted in the recent AP article: Insurers won’t cover new Alzheimer’s treatment for some customers.

“Most insurers will probably cover the drug but heavily restrict its use through things like requiring pre-approval,” said Greg Warren, a health actuary and member of the Society of Actuaries.

Read the full article at the link below.